Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions

The goal of cancer vaccines is to induce antitumor immunity that ultimately will reduce tumor burden in tumor environment. Several strategies involving dendritic cells- (DCs)- based vaccine incorporating different tumor-associated antigens to induce antitumor immune responses against tumors have bee...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & developmental immunology 2010-01, Vol.2010 (2010), p.1-14
Main Authors: Koido, Shigeo, Homma, Sadamu, Hara, Eiichi, Namiki, Yoshihisa, Takahara, Akitaka, Komita, Hideo, Nagasaki, Eijiro, Ito, Masaki, Ohkusa, Toshifumi, Gong, Jianlin, Tajiri, Hisao
Format: Article
Language:English
Subjects:
Amino acids
Animals
Antigens, Neoplasm - immunology
Cancer
Cancer therapies
Cancer Vaccines
Cell Fusion - methods
Clinical Trials as Topic
Dendritic Cells - immunology
Hepatology
Humans
Immunology
Lymphocyte Activation
Medical research
Medicine
Neoplasms - immunology
Neoplasms - pathology
Neoplasms - therapy
Regulation
Review
T-Lymphocytes, Cytotoxic - immunology
Tumor Escape - immunology
Tumor Microenvironment - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c596t-9628824337cba01b5cd34210362253e54f8cc4281d155280f21c85967e2d50703
cites cdi_FETCH-LOGICAL-c596t-9628824337cba01b5cd34210362253e54f8cc4281d155280f21c85967e2d50703
container_end_page 14
container_issue 2010
container_start_page 1
container_title Clinical & developmental immunology
container_volume 2010
creator Koido, Shigeo
Homma, Sadamu
Hara, Eiichi
Namiki, Yoshihisa
Takahara, Akitaka
Komita, Hideo
Nagasaki, Eijiro
Ito, Masaki
Ohkusa, Toshifumi
Gong, Jianlin
Tajiri, Hisao
description The goal of cancer vaccines is to induce antitumor immunity that ultimately will reduce tumor burden in tumor environment. Several strategies involving dendritic cells- (DCs)- based vaccine incorporating different tumor-associated antigens to induce antitumor immune responses against tumors have been tested in clinical trials worldwide. Although DCs-based vaccine such as fusions of whole tumor cells and DCs has been proven to be clinically safe and is efficient to enhance antitumor immune responses for inducing effective immune response and for breaking T-cell tolerance to tumor-associated antigens (TAAs), only a limited success has occurred in clinical trials. This paper reviews tumor immune escape and current strategies employed in the field of tumor/DC fusions vaccine aimed at enhancing activation of TAAs-specific cytotoxic T cells in tumor microenvironment.
doi_str_mv 10.1155/2010/516768
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9bcbc88057804adab53162508cf3d31a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9bcbc88057804adab53162508cf3d31a</doaj_id><sourcerecordid>762482975</sourcerecordid><originalsourceid>FETCH-LOGICAL-c596t-9628824337cba01b5cd34210362253e54f8cc4281d155280f21c85967e2d50703</originalsourceid><addsrcrecordid>eNqFkc2LFDEQxYMo7rp68qw0XgRlnHx_gAgyujqwIMh6DukkPZuhu7Mm3cr899ba6-B68ZSi8qvHq3oIPSX4DSFCrCkmeC2IVFLfQ6dEcbyiguH7x5rSE_So1j3GUBv9EJ1Qgrk2hp2it1_jbu7dlPLY5K65nIdcmu0wzGOaDk17WDrrD3EMJU3JN5vY9835XGGgPkYPOtfX-OT2PUPfzj9ebj6vLr582m7eX6y8MHJaGUm1ppwx5VuHSSt8YBwsMEnBaBS8095zqkmAdajGHSVew6SKNAisMDtD20U3ZLe31yUNrhxsdsn-buSys66AuT5a0_rWa42F0pi74FrBiKQCa9-xwIgDrXeL1vXcDjH4OE7F9XdE7_6M6cru8g9LjYSbKRB4eStQ8vc51skOqXq4ihtjnqtVknJNjRJAvviH3Oe5jHApq4WQiilhAHq9QL7kWkvsjlYItjf52pt87ZIv0M__dn9k_wQKwKsFuEpjcD_Tf9SeLXAEJHbuCHOlDBHsF0nGs8Y</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>855673759</pqid></control><display><type>article</type><title>Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Wiley Open Access</source><creator>Koido, Shigeo ; Homma, Sadamu ; Hara, Eiichi ; Namiki, Yoshihisa ; Takahara, Akitaka ; Komita, Hideo ; Nagasaki, Eijiro ; Ito, Masaki ; Ohkusa, Toshifumi ; Gong, Jianlin ; Tajiri, Hisao</creator><contributor>Shevach, E.</contributor><creatorcontrib>Koido, Shigeo ; Homma, Sadamu ; Hara, Eiichi ; Namiki, Yoshihisa ; Takahara, Akitaka ; Komita, Hideo ; Nagasaki, Eijiro ; Ito, Masaki ; Ohkusa, Toshifumi ; Gong, Jianlin ; Tajiri, Hisao ; Shevach, E.</creatorcontrib><description>The goal of cancer vaccines is to induce antitumor immunity that ultimately will reduce tumor burden in tumor environment. Several strategies involving dendritic cells- (DCs)- based vaccine incorporating different tumor-associated antigens to induce antitumor immune responses against tumors have been tested in clinical trials worldwide. Although DCs-based vaccine such as fusions of whole tumor cells and DCs has been proven to be clinically safe and is efficient to enhance antitumor immune responses for inducing effective immune response and for breaking T-cell tolerance to tumor-associated antigens (TAAs), only a limited success has occurred in clinical trials. This paper reviews tumor immune escape and current strategies employed in the field of tumor/DC fusions vaccine aimed at enhancing activation of TAAs-specific cytotoxic T cells in tumor microenvironment.</description><identifier>ISSN: 1740-2522</identifier><identifier>ISSN: 2314-8861</identifier><identifier>EISSN: 1740-2530</identifier><identifier>EISSN: 2314-7156</identifier><identifier>DOI: 10.1155/2010/516768</identifier><identifier>PMID: 21048993</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Amino acids ; Animals ; Antigens, Neoplasm - immunology ; Cancer ; Cancer therapies ; Cancer Vaccines ; Cell Fusion - methods ; Clinical Trials as Topic ; Dendritic Cells - immunology ; Hepatology ; Humans ; Immunology ; Lymphocyte Activation ; Medical research ; Medicine ; Neoplasms - immunology ; Neoplasms - pathology ; Neoplasms - therapy ; Regulation ; Review ; T-Lymphocytes, Cytotoxic - immunology ; Tumor Escape - immunology ; Tumor Microenvironment - immunology</subject><ispartof>Clinical &amp; developmental immunology, 2010-01, Vol.2010 (2010), p.1-14</ispartof><rights>Copyright © 2010 Shigeo Koido et al.</rights><rights>Copyright © 2010 Shigeo Koido et al. Shigeo Koido et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2010 Shigeo Koido et al. 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c596t-9628824337cba01b5cd34210362253e54f8cc4281d155280f21c85967e2d50703</citedby><cites>FETCH-LOGICAL-c596t-9628824337cba01b5cd34210362253e54f8cc4281d155280f21c85967e2d50703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/855673759/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/855673759?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21048993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Shevach, E.</contributor><creatorcontrib>Koido, Shigeo</creatorcontrib><creatorcontrib>Homma, Sadamu</creatorcontrib><creatorcontrib>Hara, Eiichi</creatorcontrib><creatorcontrib>Namiki, Yoshihisa</creatorcontrib><creatorcontrib>Takahara, Akitaka</creatorcontrib><creatorcontrib>Komita, Hideo</creatorcontrib><creatorcontrib>Nagasaki, Eijiro</creatorcontrib><creatorcontrib>Ito, Masaki</creatorcontrib><creatorcontrib>Ohkusa, Toshifumi</creatorcontrib><creatorcontrib>Gong, Jianlin</creatorcontrib><creatorcontrib>Tajiri, Hisao</creatorcontrib><title>Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions</title><title>Clinical &amp; developmental immunology</title><addtitle>Clin Dev Immunol</addtitle><description>The goal of cancer vaccines is to induce antitumor immunity that ultimately will reduce tumor burden in tumor environment. Several strategies involving dendritic cells- (DCs)- based vaccine incorporating different tumor-associated antigens to induce antitumor immune responses against tumors have been tested in clinical trials worldwide. Although DCs-based vaccine such as fusions of whole tumor cells and DCs has been proven to be clinically safe and is efficient to enhance antitumor immune responses for inducing effective immune response and for breaking T-cell tolerance to tumor-associated antigens (TAAs), only a limited success has occurred in clinical trials. This paper reviews tumor immune escape and current strategies employed in the field of tumor/DC fusions vaccine aimed at enhancing activation of TAAs-specific cytotoxic T cells in tumor microenvironment.</description><subject>Amino acids</subject><subject>Animals</subject><subject>Antigens, Neoplasm - immunology</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cancer Vaccines</subject><subject>Cell Fusion - methods</subject><subject>Clinical Trials as Topic</subject><subject>Dendritic Cells - immunology</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Immunology</subject><subject>Lymphocyte Activation</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - pathology</subject><subject>Neoplasms - therapy</subject><subject>Regulation</subject><subject>Review</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><subject>Tumor Escape - immunology</subject><subject>Tumor Microenvironment - immunology</subject><issn>1740-2522</issn><issn>2314-8861</issn><issn>1740-2530</issn><issn>2314-7156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFkc2LFDEQxYMo7rp68qw0XgRlnHx_gAgyujqwIMh6DukkPZuhu7Mm3cr899ba6-B68ZSi8qvHq3oIPSX4DSFCrCkmeC2IVFLfQ6dEcbyiguH7x5rSE_So1j3GUBv9EJ1Qgrk2hp2it1_jbu7dlPLY5K65nIdcmu0wzGOaDk17WDrrD3EMJU3JN5vY9835XGGgPkYPOtfX-OT2PUPfzj9ebj6vLr582m7eX6y8MHJaGUm1ppwx5VuHSSt8YBwsMEnBaBS8095zqkmAdajGHSVew6SKNAisMDtD20U3ZLe31yUNrhxsdsn-buSys66AuT5a0_rWa42F0pi74FrBiKQCa9-xwIgDrXeL1vXcDjH4OE7F9XdE7_6M6cru8g9LjYSbKRB4eStQ8vc51skOqXq4ihtjnqtVknJNjRJAvviH3Oe5jHApq4WQiilhAHq9QL7kWkvsjlYItjf52pt87ZIv0M__dn9k_wQKwKsFuEpjcD_Tf9SeLXAEJHbuCHOlDBHsF0nGs8Y</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Koido, Shigeo</creator><creator>Homma, Sadamu</creator><creator>Hara, Eiichi</creator><creator>Namiki, Yoshihisa</creator><creator>Takahara, Akitaka</creator><creator>Komita, Hideo</creator><creator>Nagasaki, Eijiro</creator><creator>Ito, Masaki</creator><creator>Ohkusa, Toshifumi</creator><creator>Gong, Jianlin</creator><creator>Tajiri, Hisao</creator><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><general>Hindawi Limited</general><general>Wiley</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20100101</creationdate><title>Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions</title><author>Koido, Shigeo ; Homma, Sadamu ; Hara, Eiichi ; Namiki, Yoshihisa ; Takahara, Akitaka ; Komita, Hideo ; Nagasaki, Eijiro ; Ito, Masaki ; Ohkusa, Toshifumi ; Gong, Jianlin ; Tajiri, Hisao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c596t-9628824337cba01b5cd34210362253e54f8cc4281d155280f21c85967e2d50703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Amino acids</topic><topic>Animals</topic><topic>Antigens, Neoplasm - immunology</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cancer Vaccines</topic><topic>Cell Fusion - methods</topic><topic>Clinical Trials as Topic</topic><topic>Dendritic Cells - immunology</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Immunology</topic><topic>Lymphocyte Activation</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - pathology</topic><topic>Neoplasms - therapy</topic><topic>Regulation</topic><topic>Review</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><topic>Tumor Escape - immunology</topic><topic>Tumor Microenvironment - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koido, Shigeo</creatorcontrib><creatorcontrib>Homma, Sadamu</creatorcontrib><creatorcontrib>Hara, Eiichi</creatorcontrib><creatorcontrib>Namiki, Yoshihisa</creatorcontrib><creatorcontrib>Takahara, Akitaka</creatorcontrib><creatorcontrib>Komita, Hideo</creatorcontrib><creatorcontrib>Nagasaki, Eijiro</creatorcontrib><creatorcontrib>Ito, Masaki</creatorcontrib><creatorcontrib>Ohkusa, Toshifumi</creatorcontrib><creatorcontrib>Gong, Jianlin</creatorcontrib><creatorcontrib>Tajiri, Hisao</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Clinical &amp; developmental immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koido, Shigeo</au><au>Homma, Sadamu</au><au>Hara, Eiichi</au><au>Namiki, Yoshihisa</au><au>Takahara, Akitaka</au><au>Komita, Hideo</au><au>Nagasaki, Eijiro</au><au>Ito, Masaki</au><au>Ohkusa, Toshifumi</au><au>Gong, Jianlin</au><au>Tajiri, Hisao</au><au>Shevach, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions</atitle><jtitle>Clinical &amp; developmental immunology</jtitle><addtitle>Clin Dev Immunol</addtitle><date>2010-01-01</date><risdate>2010</risdate><volume>2010</volume><issue>2010</issue><spage>1</spage><epage>14</epage><pages>1-14</pages><issn>1740-2522</issn><issn>2314-8861</issn><eissn>1740-2530</eissn><eissn>2314-7156</eissn><abstract>The goal of cancer vaccines is to induce antitumor immunity that ultimately will reduce tumor burden in tumor environment. Several strategies involving dendritic cells- (DCs)- based vaccine incorporating different tumor-associated antigens to induce antitumor immune responses against tumors have been tested in clinical trials worldwide. Although DCs-based vaccine such as fusions of whole tumor cells and DCs has been proven to be clinically safe and is efficient to enhance antitumor immune responses for inducing effective immune response and for breaking T-cell tolerance to tumor-associated antigens (TAAs), only a limited success has occurred in clinical trials. This paper reviews tumor immune escape and current strategies employed in the field of tumor/DC fusions vaccine aimed at enhancing activation of TAAs-specific cytotoxic T cells in tumor microenvironment.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>21048993</pmid><doi>10.1155/2010/516768</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1740-2522
ispartof Clinical & developmental immunology, 2010-01, Vol.2010 (2010), p.1-14
issn 1740-2522
2314-8861
1740-2530
2314-7156
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9bcbc88057804adab53162508cf3d31a
source Open Access: PubMed Central; Publicly Available Content Database; Wiley Open Access
subjects Amino acids
Animals
Antigens, Neoplasm - immunology
Cancer
Cancer therapies
Cancer Vaccines
Cell Fusion - methods
Clinical Trials as Topic
Dendritic Cells - immunology
Hepatology
Humans
Immunology
Lymphocyte Activation
Medical research
Medicine
Neoplasms - immunology
Neoplasms - pathology
Neoplasms - therapy
Regulation
Review
T-Lymphocytes, Cytotoxic - immunology
Tumor Escape - immunology
Tumor Microenvironment - immunology
title Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A56%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20Tumor%20Immunity%20by%20Tumor/Dendritic%20Cell%20Fusions&rft.jtitle=Clinical%20&%20developmental%20immunology&rft.au=Koido,%20Shigeo&rft.date=2010-01-01&rft.volume=2010&rft.issue=2010&rft.spage=1&rft.epage=14&rft.pages=1-14&rft.issn=1740-2522&rft.eissn=1740-2530&rft_id=info:doi/10.1155/2010/516768&rft_dat=%3Cproquest_doaj_%3E762482975%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c596t-9628824337cba01b5cd34210362253e54f8cc4281d155280f21c85967e2d50703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=855673759&rft_id=info:pmid/21048993&rfr_iscdi=true